Viridian Therapeutics, Inc.\DE Income Statement
VRDN / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Revenue has declined at a 46.1% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $462.0K | $3.5M | $5.7M | $5.5M | $5.5M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | $2.5M | $2.5M | $2.8M | $2.8M |
| SG&A Expense | $95.3M | $61.1M | $95.0M | $35.2M | $25.8M | $13.3M | $11.6M | $11.0M | $10.9M | $6.8M | $7.7M | $1.4M | $1.4M |
| R&D Expense | $338.9M | $238.3M | $159.8M | $100.9M | $56.9M | $28.3M | $34.8M | $30.4M | $19.6M | $13.7M | $1.0M | $225.0K | $225.0K |
| Operating Income | -$363.4M | -$299.0M | -$254.4M | -$134.3M | -$79.7M | -$110.4M | -$42.0M | -$33.1M | -$26.5M | -$17.0M | -$11.2M | -$197.0K | -$197.0K |
| Interest Expense | - | - | - | $500.0K | - | - | - | - | - | $95.0K | $141.0K | $2.0M | $2.0M |
| Income Tax | $0 | - | - | - | - | - | - | - | - | - | $0 | $0 | - |
| Net Income | -$342.6M | -$269.9M | -$237.7M | -$129.9M | -$79.4M | -$110.7M | -$41.9M | -$32.7M | -$26.5M | -$17.3M | -$11.3M | -$2.2M | -$2.2M |
| EPS (Basic) | - | - | -$5.31 | -$4.05 | -$6.66 | -$31.13 | - | - | - | - | - | - | - |
| EPS (Diluted) | - | - | -$5.31 | -$4.05 | -$6.66 | -$31.13 | - | - | -$28.21 | -$21.02 | -$3.50 | -$6.29 | - |
| Shares Outstanding | - | 81.0M | 44.8M | 32.1M | 11.9M | 3.6M | 2.1M | 29.6M | 833.7K | 709.0K | 3.8M | 0 | 200.0K |
| Operating Margin | - | - | - | - | - | - | - | - | -5742.9% | -488.6% | -196.1% | -3.6% | -3.6% |
| Profit Margin | - | - | - | - | - | - | - | - | -5738.5% | -496.8% | -198.5% | -39.3% | -39.3% |